Larry J. Jolivette

VP, DMPK at Proteovant Therapeutics

Larry has 20+ years in drug discovery and development of small molecule, biologics, and protein degraders. Previous leadership role at GlaxoSmithKline (GSK), primarily in cardiovascular, renal, and neuroscience therapeutic areas.

Links


Org chart

Timeline

  • VP, DMPK

    November, 2021 - present